Ocumetics Reports Continued Improvement in First Group of Patients. Early Vision Results Surpass Expectations

Executive Summary

• Ocumetrics Technology Corp. reported one‑month postoperative visual acuity results for all patients in Group 1 of its first‑in‑human study of the Ocumetrics Accommodating Intraocular Lens.
• All 20+ eyes examined achieved Corrected Distance Visual Acuity (CDVA) ranging from 20/32 to 20/25, meeting or exceeding internal safety and efficacy expectations.
• The company will proceed with Group 2 surgeries in the coming weeks, indicating continued momentum toward later‑stage clinical development.

Key Details

• Study Design: First‑in‑human early feasibility study; Group 1 comprised surgeries performed on Day 1 (August 2025) and Day 2 (September 2025).
• Primary Objectives for Group 1: Confirm safety, evaluate surgical technique, assess distance vision restoration.
• One‑Month Outcomes:
• CDVA results: 20/32 to 20/25 across all patients.
• Patients entered the study with significantly impaired distance vision due to cataracts; visual gains observed as early as one month post‑op.
• Safety & Performance: No adverse events reported in the release; lens demonstrated safe implantation and strong optical performance per investigators.
• Management Commentary:
• Dean Burns, President & CEO, stated the results “met, and in some cases, exceeded internal expectations” and reinforce belief in the lens’s transformative potential.
• Dr. Doyle Stulting, Chief Medical Officer, highlighted achieving 20/32 or better vision shortly after surgery as “remarkable.”
• Next Steps: Planning for Group 2 surgeries is underway; updates expected in the coming weeks.

Notable Quotes

“We’re seeing early proof of what we set out to achieve; a next generation intraocular lens that gives a patient the vision they once had,” – Dean Burns, President & CEO.

“Achieving 20/32 or better vision this soon after surgery is remarkable… gives us great confidence as we advance to the next patient groups,” – Dr. Doyle Stulting, Chief Medical Officer.